Physician profile
Robert A Avery
NPI 1407860380
$19,744.50
in general payments reported to CMS, 2019-2025
77 companies · $3,001 in 2025
The $3,001 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,005 · 2020: $637 · 2021: $799 · 2022: $6,087 · 2023: $2,952 · 2024: $3,264 · 2025: $3,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,190 · Education: $26.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,190.46 |
| Education | $26.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $3,128.66 | 2022-2025 | Loqtorzi |
| Novartis Pharmaceuticals Corporation | $1,605.64 | 2019-2025 | |
| Pfizer INC. | $1,267.78 | 2019-2025 | |
| Genentech USA, INC. | $1,004.75 | 2019-2025 | Tecentriq, Polivy, Venclexta |
| Janssen Biotech, INC. | $891.50 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Celgene Corporation | $757.17 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Astrazeneca Pharmaceuticals Lp | $696.97 | 2019-2025 | Lynparza, Imfinzi, Enhertu |
| Abbvie INC. | $662.51 | 2019-2025 | Venclexta, Dalvance |
| Amgen INC. | $635.52 | 2019-2023 | Evenity, Prolia, Nplate |
| Merck Sharp & Dohme LLC | $616.60 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| E.R. Squibb & Sons, L.L.C. | $603.22 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Eisai INC. | $428.03 | 2019-2025 | |
| Lilly USA, LLC | $424.15 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Astellas Pharma US INC | $420.86 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Exelixis INC. | $376.32 | 2019-2025 | Cabometyx |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $375.24 | 2019-2025 | Libtayo, Eylea Hd |
| Takeda Pharmaceuticals U.S.A., INC. | $372.07 | 2019-2025 | Ninlaro, Fruzaqla, Iclusig |
| Genzyme Corporation | $369.14 | 2019-2025 | |
| Incyte Corporation | $348.55 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $340.92 | 2019-2025 | Enhertu, Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $281.17 | 2019-2025 | |
| Array Biopharma INC | $251.93 | 2020-2025 | Mektovi, Braftovi, Tukysa |
| Seagen INC. | $203.36 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Pharmacyclics LLC, An Abbvie Company | $197.51 | 2020-2023 | Imbruvica, Epkinly |
| Glaxosmithkline, LLC. | $180.13 | 2019-2025 | Jemperli, Ojjaara, Zejula |
| Aveo Pharmaceuticals, INC. | $168.00 | 2021-2025 | Fotivda |
| Gilead Sciences, INC. | $161.03 | 2019-2025 | Trodelvy |
| Kite Pharma, INC. | $158.13 | 2022-2025 | Yescarta |
| Sumitomo Pharma America, INC. | $150.88 | 2023-2025 | Orgovyx |
| Stemline Therapeutics INC. | $140.23 | 2023-2025 | Orserdu |
| Karyopharm Therapeutics INC. | $138.41 | 2021-2025 | Xpovio |
| Puma Biotechnology, INC. | $137.70 | 2019-2025 | |
| Deciphera Pharmaceuticals INC. | $134.19 | 2023-2025 | Qinlock, Romvimza, Tgct |
| Alexion Pharmaceuticals, INC. | $129.99 | 2023-2024 | Ultomiris |
| Rigel Pharmaceuticals, INC. | $108.22 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Adaptive Biotechnologies Corporation | $106.41 | 2022-2024 | Clonoseq |
| Servier Pharmaceuticals LLC | $94.55 | 2023-2025 | |
| Genmab U.S., INC. | $92.84 | 2023-2025 | Epkinly |
| Global Blood Therapeutics, INC. | $89.94 | 2021-2022 | |
| Beigene USA, INC. | $89.29 | 2022-2023 | Brukinsa |
| Pharmaessentia USA Corporation | $86.16 | 2022-2025 | Besremi |
| Myriad Genetic Laboratories, INC. | $85.98 | 2021-2024 | Bracanalysis Cdx, Myrisk |
| Tesaro, INC. | $82.06 | 2019 | |
| Jazz Pharmaceuticals INC. | $80.61 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $80.37 | 2022-2024 | |
| Blue Earth Diagnostics | $64.74 | 2023-2024 | |
| Kyowa Kirin, INC. | $58.60 | 2019-2025 | |
| Beone Medicines USA, INC. | $56.93 | 2025 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $54.51 | 2023-2025 | Monoferric |
| Dova Pharmaceuticals | $52.30 | 2019-2020 | |
| Springworks Therapeutics, INC. | $52.17 | 2025 | Ogsiveo |
| Myovant Sciences INC. | $50.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.08 | 2019-2025 | |
| Emd Serono, INC. | $37.77 | 2024-2025 | |
| Sobi, INC | $36.29 | 2023-2024 | |
| Forte Bio-Pharma LLC | $35.27 | 2022-2023 | Prolate, Nalocet |
| Novo Nordisk INC | $34.46 | 2023 | Ozempic, Rybelsus |
| Agios Pharmaceuticals, INC. | $30.93 | 2020-2025 | Pyrukynd |
| Verastem, INC. | $30.62 | 2019-2020 | |
| Morphosys, US INC. | $29.86 | 2021-2023 | Monjuvi |
| Mirati Therapeutics, INC. | $29.79 | 2023-2024 | Krazati |
| Lexicon Pharmaceuticals, INC. | $29.25 | 2019 | |
| Harrow Eye, LLC | $28.80 | 2024 | Natacyn, Iheezo, Tobradex St |
| Taiho Oncology, INC. | $28.62 | 2024-2025 | |
| Electromed, INC. | $22.56 | 2021 | |
| Blueprint Medicines Corporation | $21.96 | 2023 | Ayvakit |
| Aurobindo Pharma USA, INC. | $19.27 | 2019 | |
| Immunogen, INC. | $18.87 | 2023 | Elahere |
| Geron Corporation | $18.64 | 2025 | Rytelo |
| Apellis Pharmaceuticals, INC. | $15.85 | 2023 | Empaveli |
| Helsinn Therapeutics (U.S.), INC. | $14.96 | 2019 | |
| Acrotech Biopharma INC. | $14.70 | 2023 | Beleodaq |
| Adc Therapeutics America, INC. | $14.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.33 | 2019 | |
| Boston Scientific Corporation | $11.76 | 2022 | |
| Epizyme, INC. | $11.50 | 2021 | |
| Clovis Oncology, INC. | $6.15 | 2019 |
Drugs and devices associated with these payments
Venclexta $321Darzalex $300Kisqali $284Enhertu $275Tukysa $268Xtandi $246Imbruvica $239Padcev $225Jaypirca $224Verzenio $224Braftovi $217Mektovi $217Lenvima $213Libtayo $207Reblozyl $202Epkinly $198Keytruda $188Ninlaro $186Lynparza $183Opdivo $178Pluvicto $178Retevmo $175Jakafi $174Orgovyx $174Tecvayli $170Talvey $163Inlyta $162Tecentriq $161Adcetris $147Orserdu $140Elrexfio $135Qinlock $134Polivy $132Ultomiris $130Ibrance $121Scemblix $121Monjuvi $116Nubeqa $115Lorbrena $115Elahere $111Opdualag $106Yescarta $104Pomalyst $104Imfinzi $102Oxbryta $98.33Lutathera $98.28Xofigo $97.13Sarclisa $95.07Xpovio $90.70Piqray $89.73Erleada $88.56Fotivda $87.42Lunsumio $83.31Tibsovo $81.18Brukinsa $75.81Bosulif $74.98Paxlovid $73.60Besremi $72.30Cabometyx $71.97Udenyca $70.92Columvi $66.70Clonoseq $66.53Carvykti $65.10Posluma $64.74Eylea Hd $64.69Rezlidhia $63.66Tavalisse $63.66Phesgo $62.57Jemperli $60.58Rybrevant $59.18Prolate $58.92Loqtorzi $57.74Itovebi $55.13Monoferric $54.51Fruzaqla $52.76Comirnaty $52.73Fabhalta $52.41Ogsiveo $52.17Mekinist $51.46Trodelvy $48.33Krazati $47.86Balversa $46.95Akeega $46.95Gavreto $45.66Poteligeo $42.92Zynyz $42.01Calquence $40.89Jevtana $40.41Talzenna $40.25Eliquis $38.32Pemazyre $37.58Doptelet $36.29Stivarga $35.28Evenity $35.27Prolia $35.27Vitrakvi $34.92Vyloy $34.68Bracanalysis Cdx $34.61Rybelsus $34.46Ozempic $34.46
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.